Geode Capital Management’s SeaStar Medical ICU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$207K Buy
+55,642
New +$140K ﹤0.01% 3900
2025
Q4
Sell
-25,892
Closed -$148K 4512
2025
Q3
$148K Buy
25,892
+19,009
+276% +$146K ﹤0.01% 4027
2025
Q2
$29.3K Sell
6,883
-581
-8% -$6.7K ﹤0.01% 4315
2025
Q1
$124K Buy
7,464
+2,921
+64% +$54.9K ﹤0.01% 3977
2024
Q4
$88.2K Buy
4,543
+562
+14% +$16K ﹤0.01% 4125
2024
Q3
$170K Buy
3,981
+879
+28% +$58.8K ﹤0.01% 3957
2024
Q2
$235K Buy
3,102
+304
+11% +$32.6K ﹤0.01% 3856
2024
Q1
$514K Buy
2,798
+2,359
+537% +$462K ﹤0.01% 3602
2023
Q4
$48.5K Buy
439
+92
+27% +$13.6K ﹤0.01% 4358
2023
Q3
$22.9K Buy
347
+274
+375% +$24.7K ﹤0.01% 4591
2023
Q2
$9.54K Hold
73
﹤0.01% 4720
2023
Q1
$34K Buy
73
+11
+18% +$9.37K ﹤0.01% 4602
2022
Q4
$63K Buy
+62
New +$101K ﹤0.01% 4530

Other funds holding ICU

Geode Capital Management's ICU Position: Q1 2026 in Review

Geode Capital Management opened a new position in SeaStar Medical (ICU) in Q1 2026: 55,642 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #3900 among its holdings. This is a return to the name: Geode Capital Management previously reported a position in ICU as recently as Q3 2025.

Geode Capital Management first reported a position in ICU in Q4 2022 and has held it in 13 quarters since. The position peaked at $514K in Q1 2024. 17 funds tracked by Wall St. Rank hold ICU as of Q1 2026.

  • Geode Capital Management held 55,642 shares of SeaStar Medical worth $207K as of Q1 2026.
  • SeaStar Medical was a new Geode Capital Management position in Q1 2026.
  • SeaStar Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3900 holding.
  • Geode Capital Management first reported a position in SeaStar Medical in Q4 2022 and has held it in 13 quarters since.
  • Geode Capital Management's SeaStar Medical position peaked at $514K in Q1 2024.
  • 17 funds tracked by Wall St. Rank held SeaStar Medical as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.